Magellan Investment Partners, an Australian investment management company, released its second-quarter 2026 investor letter for “Magellan Global Opportunities Fund”. A copy of the letter can be downloaded here. The Fund invests in companies with sustainable competitive advantages that generate returns exceeding their cost of capital over time. In Q2, the global stock market rose 13.8%, reversing the stagflation narrative, with energy prices declining after US–Iran tensions eased. Focus shifted to chip stocks and data centre beneficiaries. Regionally, markets’ performance reflected the tech rebound and energy decline. Macro backdrop improved in the quarter with relief from avoiding a severe energy shock, though growth and inflation concerns kept central banks cautious. The portfolio gained 4.3% in the quarter, lagging the 12.5% benchmark rise, driven by bubble-like conditions in semiconductors and data centre supply chains. For insights into their key selections for 2026, please review the Strategy’s top five holdings.
In its Q2 2026 investor letter, Magellan Global Opportunities Fund highlighted UnitedHealth Group Incorporated (NYSE:UNH). UnitedHealth Group Incorporated (NYSE:UNH) is a multinational health benefits company based in Eden Prairie, Minnesota. On July 15, 2026, UnitedHealth Group Incorporated (NYSE:UNH) stock closed at $418.52 per share. One-month return of UnitedHealth Group Incorporated (NYSE:UNH) was 4.38%, and its shares gained 45.28% over the past 52 weeks. UnitedHealth Group Incorporated (NYSE:UNH) has a market capitalization of $380.08 billion.
Magellan Global Opportunities Fund stated the following regarding UnitedHealth Group Incorporated (NYSE:UNH) in its Q2 2026 investor update:
“The largest contributors to the portfolio’s performance over the quarter were TSMC, UnitedHealth Group and Adidas. UnitedHealth Group Incorporated (NYSE:UNH) recovered from depressed levels due to a strong 1Q result with the medical care ratio improving to 83.9% (from 84.8% a year earlier), prompting management to raise FY26 adjusted EPS guidance. The result reflected a prioritisation of margin recovery over membership growth, including trimming Medicare Advantage membership and restoring operational discipline at Optum Health. Softer industry-wide medical cost and utilisation trends and a larger than-proposed 2027 Medicare Advantage rate increase further supported sentiment.”
UnitedHealth Group Incorporated (NYSE:UNH) is in 14th position on our list of 40 Most Popular Stocks Among Hedge Funds. According to our database, 130 hedge fund portfolios held UnitedHealth Group Incorporated (NYSE:UNH) at the end of the first quarter, compared to 145 in the previous quarter. In Q1 2026, UnitedHealth Group Incorporated (NYSE:UNH) reported revenues of nearly $111.7 billion, representing a 2% increase from Q1 2025. While we acknowledge the risk and potential of UnitedHealth Group Incorporated (NYSE:UNH) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than UnitedHealth Group Incorporated (NYSE:UNH) and that has 10,000% upside potential, check out our report about this cheapest AI stock.
In another article, we covered UnitedHealth Group Incorporated (NYSE:UNH) and shared the list of stocks that will make you rich over the next 3 years. In addition, please check out our hedge fund investor letters Q2 2026 page for more investor letters from hedge funds and other leading investors.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.
Disclosure: None. This article is originally published at Insider Monkey.
